Concepedia

Karyn Colman

KC

Statistics

Publications

9

Citations

639

H-Index

9

Active since

2002

Affiliations

GlaxoSmithKline (United States)(Current)

Genomics Institute of the Novartis Research Foundation

Novartis (United States)

Pfizer (United States)

Boehringer Ingelheim (United States)

Karyn Colman is an author at GlaxoSmithKline (United States) specializing in toxicology, pharmacology, and medicine.

Publications per year

2002–2022

9

Publications

9

Phenotypic landscape of intestinal organoid regeneration

Ilya Lukonin, Denise Serra, Ludivine Challet Meylan et al. · Nature · 2020 · 283 citations · Full text

Life Sciences, Biology, Cell Biology +14

An Analysis of Pharmaceutical Experience with Decades of Rat Carcinogenicity Testing

Frank D. Sistare, Daniel Morton, Carl L. Alden et al. · Toxicologic Pathology · 2011 · 152 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133

Yahu A. Liu, Qihui Jin, Yefen Zou et al. · Journal of Medicinal Chemistry · 2020 · 77 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Nonproliferative and Proliferative Lesions of the Dog

Jochen Woicke, Muthafar Al-Haddawi, Jean-Guy Bienvenu et al. · Toxicologic Pathology · 2021 · 41 citations

Veterinary Medicine, Pathology, Toxicology +13

Endocardial Myxomatous Change in Harlan Sprague-Dawley Rats (Hsd:S—D) and CD-1 Mice: Its Microscopic Resemblance to Drug-Induced Valvulopathy in Humans

Chandikumar S. Elangbam, Karyn Colman, Ruth M. Lightfoot et al. · Toxicologic Pathology · 2002 · 28 citations · Full text

Medicine, Cardiology, Toxicology +9

1–5 of 9